DN24-02

5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sun, 06/26/11 - 12:03 pm
Dendreon
prostate cancer
DN24-02
Neuvenge
Provenge
Oncothyreon
Stimuvax
colorectal cancer
breast cancer
Keryx